Creative Commons source reading · Neuromuscular and peripheral nerve disorders
Insulin-regulated serine and lipid metabolism drive peripheral neuropathy.
Michal K Handzlik; Jivani M Gengatharan; Katie E Frizzi; Grace H McGregor; Cameron Martino; Gibraan Rahman; Antonio Gonzalez; Ana M Moreno; Courtney R Green; Lucie S Guernsey; Terry Lin; Patrick Tseng; Yoichiro Ideguchi; Regis J Fallon; Amandine Chaix; Satchidananda Panda; Prashant Mali; Martina Wallace; Rob Knight; Marin L Gantner; Nigel A Calcutt; Christian M Metallo
Originally published in Nature · 2023-01-25
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Diabetes represents a spectrum of disease in which metabolic dysfunction damages multiple organ systems including liver, kidneys and peripheral nerves 1,2 . Although the onset and progression of these co-morbidities are linked with insulin resistance, hyperglycaemia and dyslipidaemia 3-7 , aberrant non-essential amino acid (NEAA) metabolism also contributes to the pathogenesis of diabetes 8-10 . Serine and glycine are closely related NEAAs whose levels are consistently reduced in patients with metabolic syndrome 10-14 , but the mechanistic drivers and downstream consequences of this metabotype remain unclear. Low systemic serine and glycine are also emerging as a hallmark of macular and peripheral nerve disorders, correlating with impaired visual acuity and peripheral neuropathy 15,16 . Here we demonstrate that aberrant serine homeostasis drives serine and glycine deficiencies in diabetic mice, which can be diagnosed with a serine tolerance test that quantifies serine uptake and disposal.
Discussion
Here we describe how direct or indirect induction of chronic, systemic serine deficiency alters lipid homeostasis and contributes to diabetic peripheral neuropathy. Modulating dyslipidaemia with myriocin or 1-deoxysphingolipid biosynthesis with serine supplementation both mitigate thermal and tactile hypoalgesia in obese diabetic mice.
Editorial reading guide
- Which patient population and reference standard did the authors use?
- Was the finding validated in a separate cohort, and how might patient selection affect it?
